about
Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthoodMemory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancerDefining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportReduced cerebral blood flow response and compensation among patients with untreated hypertension.The impact of cognitive function on medication management: three studies.Brain function, cognition, and the blood pressure response to pharmacological treatment.Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults.Evolution of an innovative approach to the delivery of in-person training in the responsible conduct of research.The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohortNetwork-level structural abnormalities of cerebral cortex in type 1 diabetes mellitus.Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure.Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetesDo words matter? Incongruent responses to inconsistently worded AUDIT-C alcohol screening instrumentsPredictive Utility of Brief Alcohol Use Disorders Identification Test (AUDIT) for human immunodeficiency virus antiretroviral medication nonadherence.Relationships among obstructive sleep apnea, anthropometric measures, and neurocognitive functioning in adolescents with severe obesity.Age of Childhood Onset in Type 1 Diabetes and Functional Brain Connectivity in Midlife.Patterns of change in cognitive function with anastrozole therapy.Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 DiabetesResting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables.Attributes of researchers and their strategies to recruit minority populations: results of a national survey.Evaluating the effects of treatment for medical disorders: has the value of neuropsychological assessment been fully realized?A Randomized Controlled Trial to Compare Computer-assisted Motivational Intervention with Didactic Educational Counseling to Reduce Unprotected Sex in Female Adolescents.Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processingLong-chain omega-3 fatty acids and optimization of cognitive performance.clinical research, innovative practice and IRB review: identifying and respecting boundaries.Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications TrialCommunity Partnered Research Ethics Training in Practice: A Collaborative Approach to Certification.Cognition and diabetes: a lifespan perspective.Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?Long-term effect of diabetes and its treatment on cognitive function.Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complicationsThe catechol-o-methyltransferase Val158 Met polymorphism modulates organization of regional cerebral blood flow response to working memory in adults.Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer.Glycemic control and hypoglycemia: is the loser the winner? Response to Perlmuter et alAn exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.Diabetes and cognitive dysfunction.Health effects of long-term solvent exposure among women in blue-collar occupations.Associations between recent severe hypoglycemia, retinal vessel diameters, and cognition in adults with type 1 diabetesSubgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients.
P50
Q24628945-045FBCC6-DF43-464A-8D58-0D233E3D772AQ24634011-FF883A96-E2D6-4936-A1E5-B0C3C223FD41Q27687598-A936F4C7-B56B-46AE-9C76-3240B1EEAAF1Q30988026-347DBA44-3A53-43DC-9A34-E2A9E60608ABQ33596657-2E6F4DA7-79F3-419E-8513-7349E837AB21Q34127219-5F49E00E-E47F-4E26-8BB0-697C7D60FB28Q34374952-13EFB717-DD56-4E76-B9D5-F1D8C7614F70Q34550769-1E6C6F85-411E-4488-8D68-ECC32AAC0102Q34595620-03C17611-FAF6-4430-9777-0275A421EC3BQ34994167-7B0A0F0C-2394-4E8C-8003-D9717A78A134Q35109167-8179A986-14F9-4110-9E6B-4A0BCFB8681EQ35523936-056CC113-13F1-4300-BB8E-CE08F07D0E7FQ35639973-E24B1799-0F64-4714-9B80-BD99B6FC551FQ35786120-B911DFAA-4CC4-490A-B240-8049DBA842FBQ35786125-D1EA6479-F614-460C-B0B8-F7E4D7A573F0Q35815595-41F67436-1114-47D5-8601-31CE8D81CEF5Q35854978-C49A0C72-B53C-4E5D-9F8B-521B487A1141Q35883135-CE909028-57CD-48D6-9454-EDF8E0401F10Q35973261-67A560ED-E1D1-487D-A3CA-0C7F832F6542Q36047643-E9A564D8-1397-4CD2-B2D6-B520BCAAF648Q36310017-8D5F5831-2C08-450F-9D27-D095BEE2E6C7Q36327135-D01CEAC6-7025-42D2-8FDB-AC2CF5AC4DD8Q36349615-BCE338F3-9F62-42B7-BF7E-20164D258B7DQ36477954-6892B192-19AD-4906-A34F-3E992BA90FF7Q36525454-95432A8F-5D0A-407E-9E17-7BF9D105AF71Q36748534-7EC3F1B6-59E1-421C-B9B8-30D9983DF0B8Q36906182-DF9CB3F1-E6D9-49C6-B696-DE73ACCD42A1Q37029780-53ACB27F-EF68-4FC0-BBDE-82700007231BQ37061183-E9CDB1D5-8FB5-4EE0-8A53-74012318B314Q37100148-C28117F7-078B-49E2-B51F-4E0486F6C754Q37239753-820A0D3A-EC75-4B24-94FE-FC2DAF0BDAB3Q37281771-2F3A523A-C8A2-4F62-8FBA-32A3352EE5A6Q37281994-7884A455-C458-4C72-883B-3F281A966898Q37648136-8156CD8C-5A34-4B95-A847-348A29A755B4Q37676996-2A208320-4A9D-4BDB-96A1-790A2726165EQ37691657-04A9F64D-5DAC-4352-9341-A551460FE5E0Q38017477-C5796629-D919-45C1-BDF2-67072CCAAF43Q38555733-298E95E3-2426-4958-810A-06E0F4C7A00CQ38823846-A223C2D1-00AF-437A-9291-879F3CC84101Q38872822-353B3C01-1524-4F2C-A776-94C80D2FE4E4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher M. Ryan
@ast
Christopher M. Ryan
@en
Christopher M. Ryan
@es
Christopher M. Ryan
@nl
Christopher M. Ryan
@sl
type
label
Christopher M. Ryan
@ast
Christopher M. Ryan
@en
Christopher M. Ryan
@es
Christopher M. Ryan
@nl
Christopher M. Ryan
@sl
prefLabel
Christopher M. Ryan
@ast
Christopher M. Ryan
@en
Christopher M. Ryan
@es
Christopher M. Ryan
@nl
Christopher M. Ryan
@sl
P106
P1153
35596784700
P21
P31
P496
0000-0003-4278-917X